NCT01713595View on ClinicalTrials.gov

Safety Study of Inhaled Saline in Acute Lung Injury

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Pulmonary Edema
Interventions
DRUG

Hypertonic Saline Aerosol

A single 5ml dose of 7% Saline aerosol

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01713595 - Safety Study of Inhaled Saline in Acute Lung Injury | Biotech Hunter | Biotech Hunter